Reports

Sale

Optical Genome Mapping Market

Global Optical Genome Mapping Market Size, Share, Price, Forecast: By Product: Consumables, Instruments; By Application: Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others; By End User: Research and Academic Institutions, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Optical Genome Mapping Market Outlook

The global optical genome mapping market size is anticipated to grow at a CAGR of 19.7% during the forecast period of 2024-2032, driven by the increasing accessibility and affordability of technology in the field across the globe.

 

Optical Genome Mapping: Introduction

Optical genome mapping is an innovative technology which enables the comprehensive analysis and mapping of the entire genome of an organism. Optical genome mapping (OGM) images extra-long linear, and single DNA molecules (median size > 250 kb) that are labeled at certain locations. This tedious technique has been updated by Bionano Genomics and is now popular as “optical mapping for structural variation analysis by whole-genome mapping.

 

Optical genome mapping allows researchers and scientists to study genetic differences, structural rearrangements, and other genomic alterations with high accuracy and resolution. Optical genome mapping provides valuable insights into genomic disorders, cancer research, personalized medicine, and other fields of genomics.

 

Global Optical Genome Mapping Market Analysis

The continuous advancements in technology is leading to improved efficiency, accuracy, and scalability of the optical genome mapping platforms, resulting in optical genome mapping market growth. The development in optical genome mapping platforms has enabled faster and more cost-effective genome mapping, making it more accessible to researchers and clinicians. The increasing use of optical genome mapping platforms to detect and analyze genetic abnormalities related to several diseases and disorders is taking place. It provides a detailed view of the genome, allowing for the identification of structural differences.

 

Optical Genome Mapping Market Segmentations

Market Breakup by Product

  • Consumables 
  • Instruments

 

Market by Application

  • Genome Assembly
  • Structural Variation Detection
  • Microbial Strain Typing
  • Haplotype Phasing
  • Others

 

Market by End User

  • Research and Academic Institutions
  • Biotechnology and Pharmaceutical Companies
  • Clinical Laboratories
  • Others

 

Market Breakup by Region

  • North America  
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

 

Optical Genome Mapping Market Overview

The rapid advancements in genomics research, increasing demand for personalized medicine, and the need for detailed genomic analysis are some of the key factors which are aiding the optical genome mapping market expansion. Optical genome mapping technologies have been revolutionizing the way studies were done in order to understand genome, providing high-resolution mapping of genomic versions and structural dislocations. These technologies have discovered uses in several areas, including clinical diagnostics, pharmaceutical research, and agriculture.

 

The market for optical genome mapping is expected to grow due to the increased accessibility and affordability of technology in the field. Growing advancements in equipment design, automation, and data analysis algorithms are making optical genome mapping platforms more user-friendly and efficient. Due to this factor, the integration of optical genome mapping platforms is done in research and clinical workflows in order to achieve faster and more accurate analysis of genomic data.

 

Optical Genome Mapping Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Bionano Genomics, Inc. 
  • Nucleome Informatics Pvt Ltd 
  • PerkinElmer, Inc. 
  • Nabsys Inc. 
  • France Génomique 
  • Praxis Genomics LLC 
  • OpGen, Inc. 
  • Thermo Fisher Scientific, Inc. 
  • Illumina, Inc. 
  • HemoCue Holding AB

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Application
  • End User
  • Region
Breakup by Product
  • Consumables 
  • Instruments
Breakup by Application
  • Genome Assembly
  • Structural Variation Detection
  • Microbial Strain Typing
  • Haplotype Phasing
  • Others
Breakup by End User
  • Research and Academic Institutions
  • Biotechnology and Pharmaceutical Companies
  • Clinical Laboratories
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Bionano Genomics, Inc. 
  • Nucleome Informatics Pvt Ltd 
  • PerkinElmer, Inc. 
  • Nabsys Inc. 
  • France Génomique 
  • Praxis Genomics LLC 
  • OpGen, Inc. 
  • Thermo Fisher Scientific, Inc. 
  • Illumina, Inc. 
  • HemoCue Holding AB

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Optical Genome Mapping Market Overview 

    3.1    Global Optical Genome Mapping Market Historical Value (2017-2023) 
    3.2    Global Optical Genome Mapping Market Forecast Value (2024-2032)
4    Global Optical Genome Mapping Market Landscape
    4.1    Global Optical Genome Mapping Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Optical Genome Mapping Product Landscape
        4.2.1    Analysis by Product
        4.2.2    Analysis by Application
5    Global Optical Genome Mapping Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Optical Genome Mapping Market Segmentation 
    6.1    Global Optical Genome Mapping Market by Product
        6.1.1    Market Overview                                                                                                
        6.1.2    Consumables
        6.1.3    Instruments
    6.2    Global Optical Genome Mapping Market by Application
        6.2.1    Market Overview
        6.2.2    Genome Assembly 
        6.2.3    Structural Variation Detection 
        6.2.4    Microbial Strain Typing 
        6.2.5    Haplotype Phasing 
        6.2.6    Others
    6.3    Global Optical Genome Mapping Market by End User
        6.3.1    Market Overview
        6.3.2    Research and Academic Institutions 
        6.3.3    Biotechnology and Pharmaceutical Companies 
        6.3.4    Clinical Laboratories
        6.3.5    Others
    6.4    Global Optical Genome Mapping Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Optical Genome Mapping Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Optical Genome Mapping Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Optical Genome Mapping Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Optical Genome Mapping Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Optical Genome Mapping Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Bionano Genomics, Inc.
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Nucleome Informatics Pvt Ltd
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    PerkinElmer, Inc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Nabsys Inc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    France Génomique
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Praxis Genomics LLC
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    OpGen, Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Thermo Fisher Scientific, Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Illumina, Inc.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    HemoCue Holding AB
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Global Optical Genome Mapping Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 19.7% during the forecast period of 2024-2032, driven by the rising attempts by healthcare facilities to reduce their expenditures.

The growth of the market is driven by factors like the increasing demand for personalized medicine and the need for detailed genomic analysis.

The key trends for the market include the increasing use of optical genome mapping platforms to detect and analyze genetic abnormalities related to several diseases and disorders.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The different types of products in the market are consumables and instruments.

The product finds wide applications in genome assembly, structural variation detection, microbial strain typing, and haplotype phasing, among others.

The different types of end users in the optical genome market are research and academic institutions, biotechnology and pharmaceutical companies, and clinical laboratories, among others.

Key players involved in the market are Bionano Genomics, Inc., Nucleome Informatics Pvt Ltd, PerkinElmer, Inc., Nabsys Inc., Praxis Genomics LLC, OpGen, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., HemoCue Holding AB., and France Génomique.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER